Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica
BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ('Aclarion' or the 'Company') (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is now available in Santa Monica at Medical Imaging Center of Southern California (MICSC). Until now, MICSC has provided Nociscan exclusively at their Beverly Hills location.
'We are pleased to expand access to Nociscan in our Santa Monica location,' said Bradley Jabour, MD, founder of MICSC. 'MICSC has a proud heritage of adoption of new and novel solutions that add value to our patients and referring physician customers. Nociscan has been an integral part of our Beverly Hills service offering and by adding it in Santa Monica we are expanding our services while replicating the benefits to patients and physicians currently provided in Beverly Hills. Physicians treating low back pain are constantly striving for more and better information when diagnosing and treating patients. Nociscan is helping physicians who treat low back pain and we are pleased to offer Nociscan at both our Los Angeles locations.'
In November 2024, Dr. Jabour was highlighted in an article about Nociscan in the Radiological Society of North America edition of MAGNETOM Flash, a peer-to-peer magazine published by Siemens Healthineers. The article features two physician-user perspectives on Nociscan, one from a spine surgeon and the other from Dr. Jabour's point of view as a radiologist and imaging center owner.
Chronic low back pain (cLBP) is a global healthcare problem with approximately 266 million people worldwide suffering from degenerative spine disease and low back pain. Los Angeles is the most populous city in California, with an estimated population exceeding 3.8M people, and the second-most populous city in the United States, second only to New York City. Both Los Angeles and New York City are strategically important markets for Aclarion.
Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain.
To find a Nociscan center, view our site map here.
All organizations cited and/or quotes from individuals not part of Aclarion have reviewed and approved the contents herein.
About Aclarion, Inc.
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ('MRS'), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company's current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as 'anticipates,' 'believes' and 'expects' or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled 'Risk Factors' in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
Media Contacts:
Jennie Kim
SPRIG Consulting
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Hair Center of Turkey Achieves Amazing Hair Transplant Results With its New Hybrid Technique
ISTANBUL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Hair Center of Turkey, a leading institution in hair restoration, has announced the launch of its Hybrid Hair Transplant method, which merges the advantages of FUE Sapphire and FUE DHI techniques. The clinic is also introducing an exclusive VIP Package, specifically designed to meet the unique needs of patients from the U.S. and Canada, combining advanced medical expertise with luxury and comfort. FUE Sapphire vs. FUE DHI: Understanding the Difference FUE Sapphire: In this technique, ultra-fine sapphire blades are used to create micro-incisions for graft placement. This allows for extremely precise fue hair transplant, minimal tissue trauma, faster healing, and virtually scar-free results. The sapphire blade's smooth edges reduce friction and promote better graft survival. FUE DHI: Unlike traditional FUE, FUE DHI hair transplant uses the Choi pen to implant hair directly without opening separate channels. This gives surgeons complete control over each graft's angle, depth, and direction, allowing for highly natural-looking hair growth and dense coverage, especially in sensitive or highly visible areas. Hybrid Method: The Hybrid method combines both FUE Sapphire and FUE DHI. By integrating the precision of sapphire micro-incisions with the direct implantation control of DHI, the Hybrid technique ensures minimal trauma, rapid recovery, and optimal aesthetic outcomes, even for complex hairlines or large areas. This innovative approach offers patients the best of both worlds, delivering natural-looking, long-lasting results with maximum comfort and Package Highlights:Hair Center of Turkey's VIP Package offers more than just advanced hair transplant in Turkey. It provides a fully personalized, comfortable, and luxurious experience for international patients: Luxury Accommodation: Stay in a 5-star hotel with premium amenities for complete relaxation during your treatment. VIP Airport Transfers: Hassle-free transportation to and from the airport ensures stress-free travel. Multilingual Support: Dedicated staff fluent in English, French, Spanish, and other languages assist patients throughout their journey. Comprehensive Post-Operative Care: Continuous monitoring and follow-up, including guidance on recovery, medication, and hair care, to ensure the best possible results. Explore Istanbul: Take the opportunity to discover the city's cultural and historical landmarks, combining medical care with tourism. Expert Team & Personalized Care Under the coordination of Sinan Özer, Hair Center of Turkey prioritizes personalized care and high-quality outcomes. The clinic follows a VIP service model with limited daily procedures, ensuring each patient receives meticulous attention. Limited Daily Operations: Only a small number of procedures are performed each day, allowing the team to focus on detailed, patient-specific treatment plans. Expert Medical Team: Dr. Rasime Erkan: Dermatology specialist with extensive experience, overseeing every stage of the procedure from consultation to post-operative care. Zehra Özer: Hair transplant specialist directly involved in graft extraction, placement, and monitoring, ensuring high precision and natural results. Anesthesiologist: Responsible for administering and monitoring anesthesia throughout the procedure, ensuring patient safety, comfort, and a pain-free experience. Hands-On Supervision: Both specialists remain actively involved throughout the process to minimize risks, ensure graft survival, and optimize outcomes. Continuous Patient Support: Patients receive guidance, reassurance, and care before, during, and after the procedure, improving comfort and Center of Turkey Stands Out: Why Choose Us Hair Center of Turkey provides a unique and personalized hair transplant experience, standing out among hair transplant clinics in Turkey by combining advanced Hybrid Hair Transplant technology with expert medical supervision and exclusive VIP services, ensuring patients receive the highest quality care and natural-looking results. Key reasons to choose us: Hybrid Technique: Combines FUE Sapphire and FUE DHI for precise, natural-looking results. Expert Team: Specialists oversee every stage for high-quality outcomes. Personalized Care: Limited daily procedures ensure individual attention. VIP Services: Luxury accommodation, airport transfers, and multilingual support. Comfort & Support: Continuous guidance before, during, and after the procedure. Natural Results: Focus on hair direction, density, and aesthetics for undetectable outcomes. Special Note: Our treatments are provided by healthcare facilities that possess a health tourism authorization certificate Press Contact:Murat Sargaskar+90 530 768 61 91 sales@ Photos accompanying this announcement are available athttps://
Yahoo
an hour ago
- Yahoo
Clarity Health Care is Coming to Malvern
Unique mental health clinic to provide integrated care to Melbourne's inner south-east MELBOURNE, Australia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Clarity Health Care, a leading provider of multidisciplinary mental health services, is expanding its reach with the opening of a new clinic in Malvern, Victoria. Renowned for its integrated care model, Clarity's unique approach brings together psychologists, psychiatrists, mental health social workers, occupational therapists, and other allied health professionals under one roof. This means that clients benefit of one centralised care plan, in one single location. Clarity's model has already proven successful at its existing Fitzroy and Hobart clinics, with the model being shown to reduce readmissions rates from an average of 48% to 18.6%i. The new Malvern clinic will offer comprehensive mental health support for people across the inner south-east and beyond. Davis Lemke, CEO of Clarity Health Care, said: 'Clarity is built on the belief that mental health care works best when it's connected, compassionate, and collaborative. We're excited to bring our multidisciplinary approach to Malvern and work closely with local GPs, health professionals, and the community to ensure people have access to the support they need, when they need it.' The Malvern clinic aims to meet demand for accessible, high-quality mental health services in the area, welcoming both GP referrals and self-referrals. With flexible appointment options and a focus on continuity of care, Clarity is well-positioned to support individuals and families at all stages of their mental health journey. Located in the heart of Malvern, the new clinic is designed to offer a warm, welcoming, and therapeutic environment for clients and clinicians alike. For more information or to make a referral, visit For further information or to request an interview, please contact:Victoria Hanlon, Marketing Manager | 0467 723 004 | About Clarity Health Care Founded in 2013, Clarity Health Care aims to provide an alternative to the hospital setting for individuals experiencing severe mental illness. Clarity Health Care offers mental health care in Melbourne (Fitzroy and Malvern) and Hobart with a more comprehensive approach. The team comprises psychiatrists, psychologists, occupational therapists, mental health social workers, and registered nurses, and provides evidence-based care through various modalities that are flexible and accessible to all consumers. i New mental health clinic helping ease burden on Tasmanians
Yahoo
2 hours ago
- Yahoo
What To Expect From Premier's (PINC) Q2 Earnings
Healthcare tech company Premier (NASDAQ:PINC) will be reporting earnings this Tuesday morning. Here's what you need to know. Premier beat analysts' revenue expectations by 7.4% last quarter, reporting revenues of $261.4 million, down 8.9% year on year. It was a very strong quarter for the company, with a beat of analysts' EPS estimates and an impressive beat of analysts' full-year EPS guidance estimates. Is Premier a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Premier's revenue to decline 28.5% year on year to $250.4 million, a reversal from the 2.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.34 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Premier has missed Wall Street's revenue estimates four times over the last two years. Looking at Premier's peers in the healthcare technology for providers segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Privia Health delivered year-on-year revenue growth of 23.4%, beating analysts' expectations by 10.9%, and Omnicell reported revenues up 5%, topping estimates by 4.9%. Privia Health traded up 4% following the results while Omnicell's stock price was unchanged. Read our full analysis of Privia Health's results here and Omnicell's results here. There has been positive sentiment among investors in the healthcare technology for providers segment, with share prices up 7.2% on average over the last month. Premier is up 19.2% during the same time and is heading into earnings with an average analyst price target of $22.33 (compared to the current share price of $24.95). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
